Identification of approved drugs as potent inhibitors of pregnane X receptor activation with differential receptor interaction profiles (2018)
- Authors:
- Autor USP: WRENGER, CARSTEN - ICB
- Unidade: ICB
- DOI: 10.1007/s00204-018-2165-4
- Subjects: PARASITOLOGIA; ANTAGONISMO DE DROGAS; CÉLULAS KUPFFER
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Publisher place: Heidelberg
- Date published: 2018
- Source:
- Título do periódico: Archives of Toxicology
- ISSN: 1432-0738
- Volume/Número/Paginação/Ano: v. 92, p. 1435-1451, 2018
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
BURK, Oliver et al. Identification of approved drugs as potent inhibitors of pregnane X receptor activation with differential receptor interaction profiles. Archives of Toxicology, v. 92, p. 1435-1451, 2018Tradução . . Disponível em: https://doi.org/10.1007/s00204-018-2165-4. Acesso em: 20 abr. 2024. -
APA
Burk, O., Kuzikov, M., Kronenberger, T., Jeske, J., Keminer, O., Thasler, W. E. , et al. (2018). Identification of approved drugs as potent inhibitors of pregnane X receptor activation with differential receptor interaction profiles. Archives of Toxicology, 92, 1435-1451. doi:10.1007/s00204-018-2165-4 -
NLM
Burk O, Kuzikov M, Kronenberger T, Jeske J, Keminer O, Thasler W E , Schwab M, Wrenger C, Windshügel B. Identification of approved drugs as potent inhibitors of pregnane X receptor activation with differential receptor interaction profiles [Internet]. Archives of Toxicology. 2018 ; 92 1435-1451.[citado 2024 abr. 20 ] Available from: https://doi.org/10.1007/s00204-018-2165-4 -
Vancouver
Burk O, Kuzikov M, Kronenberger T, Jeske J, Keminer O, Thasler W E , Schwab M, Wrenger C, Windshügel B. Identification of approved drugs as potent inhibitors of pregnane X receptor activation with differential receptor interaction profiles [Internet]. Archives of Toxicology. 2018 ; 92 1435-1451.[citado 2024 abr. 20 ] Available from: https://doi.org/10.1007/s00204-018-2165-4 - Cytometric quantification of singlet oxygen in the human malaria parasite Plasmodium falciparum
- Vitamin B6-dependent enzymes in the human malaria parasite Plasmodium falciparum: a druggable target?
- The crystal structure of the Plasmodium falciparum PdxK provides an experimental model for pro-drug activation
- Metabolite transporters in trypanosomatid parasites: promising therapeutic targets but... how to deal with them?
- Chemical and genetic validation of thiamine utilization as an antimalarial drug target
- Harnessing the helminth secretome for therapeutic immunomodulators
- MRSA infections: from classical treatment to suicide drugs
- Oligomeric interfaces as a tool in drug discovery: Specific interference with activity of malate dehydrogenase of Plasmodium falciparum in vitro
- Structure of ThiM from Vitamin B1 biosynthetic pathway of Staphylococcus aureus – Insights into a novel pro-drug approach addressing MRSA infections
- Solution structures and dynamic assembly of the 24-meric plasmodial Pdx1–Pdx2 complex
Informações sobre o DOI: 10.1007/s00204-018-2165-4 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
